Clinical Trial Update: Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer

View source ↗

Summary

This ClinicalTrials.gov entry describes a prospective study hosted by Chang Gung Memorial Hospital that will profile metabolomic and immune-microbiome features …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Pancreatic Ductal Adenocarcinoma (PDAC) | Status: NOT_YET_RECRUITING